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Research Paper
Exercise for multiple sclerosis:
a single-blind randomized trial comparing
three exercise intensities
Johnny Collett1, Helen Dawes1,2, Andy Meaney1, Cath Sackley3,
Karen Barker4, Derick Wade5, Hooshang Izardi6,
James Bateman1, Joan Duda7 and Elizabeth Buckingham1
Abstract
Background: The most effective exercise dose has yet to be established for multiple sclerosis (MS).
Objective: The aim of this study was to investigate the effect of different exercise intensities in people with MS.
Methods: We completed a randomized comparator study of three cycling exercise intensities, with blinded assessment, was
carried out in Oxford. Sixty-one adults with MS who fulfilled inclusion criteria were randomized at entry into the study, using a
computer-generated list held by an exercise professional, into either: continuous (at 45% peak power, n¼ 20), intermittent
(30 sec on, 30 sec off at 90% peak power, n¼ 21) or combined (10min intermittent at 90% peak power then 10min continuous
at 45% peak power, n¼ 20) exercise for 20min twice a week for 12weeks in a leisure facility. Groups were assessed at:
baseline, halfway (6weeks), end intervention (12weeks) and follow-up (24weeks). Primary outcomemeasure was 2min walk.
Results: Fifty-five participants were included in the analysis (n¼ continuous 20, intermittent 18, combined 17). No
differences were found between groups. After 6weeks, considering all participants, 2min walk distance increased by
6.96 2.56m (95% CI: 1.81 to 12.10, effect size (es): 0.25, p< 0.01). The continuous group increased by 4.71 4.24m
(95% CI: 3.80 to 13.22, es: 0.06), intermittent by 12.94 4.71m (95% CI: 3.97 to 21.92, es: 0.28) and combined by
3.22 4.60m (95% CI: 6.01 to 12.46, es: 0.04). Two minute walk did not significantly change between further assess-
ments. Between 6 and 12weeks there was a drop in attendance that seemed to be associated with the intermittent and
combined groups; these groups also had a greater number of adverse events (leg pain during cycling most common) and
dropouts (n¼ continuous 1, intermittent 5, combined 10). Considering all participants, 6weeks of cycling exercise
produced benefits in mobility that were maintained with further sessions.
Conclusion: While no differences were found between groups, greater benefit may be associated with higher-intensity
exercise, but this may be less well tolerated.
CONSORT - trial registration number (ISRCTN89009719)
Keywords
dose, exercise, mobility, multiple sclerosis, randomized trial, rehabilitation
Date received: 26th May 2010; revised: 1st October 2010; accepted: 3rd November 2010
Introduction
The evidence for regular participation in physical activity
for healthy adults and children is compelling. Physical
activity contributes to well-being and good health for
all1,2 and the risks associatedwith participating in physical
activity at levels that promote health and well-being are
low.1 A Cochrane systematic review of exercise therapy
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for people with multiple sclerosis (MS) conﬁrms there is
good evidence that exercise can be beneﬁcial for mobility,
isometric muscle strength, physical ﬁtness and mood.3
However, many questions remain regarding optimal,
safe exercise prescription for people at diﬀerent stages
of MS. Importantly, while government guidelines exist
for healthy adults regarding safe eﬀective levels of phys-
ical activity for health and well-being, no such evidence
exists for people with MS. It remains to be established
what dose of exercise is best and whether there is an
exercise dose that is too high and may cause harm. We
do not know how many times a week a person should
train and whether they should train in short hard bursts
or train for longer but less intensely.
To date, exercise studies in people with MS have
generally not adequately controlled or monitored the
frequency, duration and intensity of exercise.4,5 To
understand exercise in this group better and to enable
comparison between exercise therapies, it is recom-
mended that dose is experimentally controlled and mea-
sured.3 Furthermore, there is consensus among reviews
of the MS exercise literature that there is a need for
studies to utilize experimental designs and reporting
that adhere to good methodological principles, in
order to provide evidence for exercise prescription.3–5
In order to explore safe eﬀective exercise intensity, we
conducted a single-blind randomized trial comparing low,
high and a combination of low and high-intensity exercise
delivered on a cycle ergometer. The study was designed so
that the exercise dose was carefully controlled and moni-
tored, and progressed with each group receiving the same
frequency and duration of exercise and performing the
same relative amount of total work per session.
Materials and methods
Design
This is a randomized comparator study of three parallel
intervention groups, with assessment to assess superior-
ity performed by an assessor blinded to group allocation.
Participants recruited to the study were allocated the
next available study number by the blinded assessor.
The study number related to a computer-generated ran-
domization list drawn up by a statistician (blocks
sequence generation) to randomize participants into con-
tinuous, intermittent or combined groups. The list was
held by two registered exercise professionals who then
delivered the intervention. Group allocation was con-
cealed from the assessor until the end of the study.
Setting
Assessments were carried out in Oxford, either at the
Nuﬃeld Orthopaedic Centre or at Oxford Brookes
University. The intervention exercise sessions were car-
ried out at Oxford Brookes University and at four com-
munity leisure centres in the Thames Valley and West
London.
Participants
After National Health Service (NHS) ethical approval
(08/H0604/3) had been obtained, 61 people with MS
were recruited to the study in accordance with the dec-
laration of Helsinki between June 2008 and April 2009.
Candidates for the study were people with MS over
18 years of age identiﬁed through local neurologists or
self-referral. Local MS society branches were made
aware of the trial and given contact details; individuals
from the branches were then able to self-refer to the
study. If they were recruited through this method,
their general practitioner or consultant neurologist
was contacted to ensure suitability. They were not
admitted to the study if any of the following criteria
were present: (1) a medical condition or complication
that would preclude safe participation in exercise, as
indicated by the referring neurologist or their general
practitioner; (2) unable to walk for 2min, with walking
aid as necessary; (3) not able to sit on a cycle ergometer
and complete 60 s unloaded exercise; (4) a relapse or
sudden change in their MS symptoms within the previ-
ous 2weeks; (5) a condition aﬀecting the central ner-
vous system other than MS; or (6) insuﬃcient mental
capacity to consent.
Intervention
The intervention schedule for all groups was two exercise
sessions per week for 12weeks. Each exercise session
consisted of 20min on a static bike at a convenient
time (including non-working hours and weekends) at
one of the participating centres. If participants could
not achieve 20min of exercise they were encouraged to
continue for as long as possible by the delivering exercise
professional. A cadence of 50 rpm was intended through-
out the exercise; if participants could not achieve 50 rpm
they were encouraged to cycle as fast as possible (but not
less than 40 rpm). Participants were randomized into
three groups. Groups were primarily designed so that
the same relative work was performed per session but
delivered at diﬀerent intensities. The intensity of each
group was selected so that the exercise was achievable
while being suﬃcient to elicit a training response at each
intensity.6 Relative exercise intensity was determined for
each individual from a baseline ﬁtness test and prog-
ressed at a 6week ﬁtness test.
. The combined group performed 10min of intermit-
tent cycling (30 s cycling/30 s rest) at 90% peak
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workload immediately followed by 10min continu-
ous cycling at 45% peak workload (Combined).
. The continuous group performed continuous cycling
at 45% of the peak workload from the exercise test
(Continuous).
. The intermittent group performed 30 s cycling fol-
lowed by 30 s rest at 90% of the peak workload
from exercise test (Intermittent).
To monitor the delivery of intervention and the ﬁdel-
ity of the exercise delivery between exercise profes-
sionals, detailed training data were recorded by the
exercise professionals during the exercise sessions.
Reporting this information is beyond the scope of the
current report. However, exercise session heart rate and
attendance are displayed (Table 3). Heart rate data
were recorded throughout training and are reported
from the ﬁrst exercise sessions during week 1 and
week 11 as a percentage of maximum heart rate calcu-
lated from age (% max heart rate¼ 220 age).
Assessment
Assessments were performed at baseline, 6weeks (half-
way through intervention), 12weeks (end intervention)
and 24weeks (follow-up). Measurements were made by
the same assessor blinded to intervention allocation.
No instruction regarding the continuation of exercise
was given to the participants during the follow-up
period.
Function
The primary outcome measure for the study was the
2min walk test. Participants were asked to walk as
far as they could in 2min along a 16m indoor walkway,
turning around cones at each end; the distance walked
was measured.7 Walking was also assessed using the
timed up and go test (TUG), and for this test partici-
pants were required to stand up from a chair, walk 3m
around a cone, return to the chair and sit down as fast
as they could.8 The time taken to complete the TUG
was recorded. Walking tests were performed once per
assessment; no encouragement was given during the
tests. Leg extensor power was measured using a ‘leg
power meter’ (Medical Laboratory Workshops,
Nottingham, UK).9 The maximum power achieved
from each leg separately was recorded and reported
as an average of the two legs.
Questionnaires
At each assessment the following questionnaires were
administered: the Barthel Index (Barthel) was used to
measure independence in activities of daily living (0–20
scale, with 20 indicating greatest independence); per-
ceived health status was measured using the Short
Form (36) Health Survey (SF-36)10 (0–100 scale, with
100 indicating high health status); and fatigue was mea-
sured using the Fatigue Severity Scale (FSS) (average
score from nine statements rated 1 to 7, with 7 indicat-
ing strong agreement with the statement).11
Exercise test
In order to determine individual ﬁtness levels, a step-
wise incremental exercise test was performed on a cycle
ergometer (Monarch 874E, Monark Exercise AB,
Vansbro, Sweden). Prior to the test participants were
asked to refrain from the consumption of alcohol, cig-
arettes, food and caﬀeine and to avoid exercise for a
period of 3 h, and were also screened for suitability to
take part in physical activity using the Physical Activity
Readiness Questionnaire (PAR-Q) questionnaire12
and blood pressure measurement.6 The test started
with unloaded cycling. Participants were asked to main-
tain a cadence of 50 revolutions per minute (rpm); if
participants could not achieve 50 rpm they were
encouraged to cycle as fast as the could (but not less
than 40 rpm). Every 2min the external load on the cycle
ergometer was increased by 0.5 kg, which equated to
25W increase in workload at 50 rpm. The test was
terminated when the participant reached volitional
exhaustion or the cadence dropped by 10 rpm. At the
end of each increment heart rate was recorded from a
watch receiving telemetry from a monitor strapped
around the participant’s chest (Polar heart rate moni-
tor, Polar Electro, Finland). The peak power from the
test was used to determine the relative exercise intensity
during the intervention.
Data analysis
To investigate the beneﬁcial eﬀect of exercise on outcome
assessments and the diﬀerential eﬀect between groups, a
pragmatic approach was used to determine sample size.
Based on data from a previous study on treadmill training
in MS compared with no intervention13 to identify a
change of 10.8m on the 2min walk (with an alpha of
0.05 and 90% power), 11 participants would be required.
Considering this calculation, the non-speciﬁc eﬀect of
cycle ergometer training and to allow for dropouts, we
aimed to recruit 20 people to each group.
Data were analysed based on the intention-to-treat
principle.14 In this study all participants who received
at least one intervention session were included in the
analysis. Statistical analysis was performed in SPSS 17.
For incomplete data sets multiple imputation, with ﬁve
imputations, provided multiple statistical estimates for
missing data in order to perform the following
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statistical analysis.15 One-way ANOVA was used to
assess diﬀerences between groups at baseline and diﬀer-
ence in intervention sessions attended. Repeated mea-
sures ANOVA were used to assess diﬀerences between
assessments and between groups; alpha was set at
p< 0.05. Baseline data are reported as means and stan-
dard deviations, except for the Barthel ADL index,
where the median and range are reported. Assessment
data are reported as mean change and standard error
from previous assessment; 95% conﬁdence intervals are
also reported.
Results
Sixty-one people with MS were recruited from Thames
Valley MS society branches and by neurologist referral
between June 2008 and April 2009 and randomized into
intervention groups. Participant ﬂow is shown in
Figure 1. After randomization but prior to receiving
the intervention session three people withdrew from
the intermittent group: one due to MS relapse and
fall, one was unable to tolerate the cycle ergometer
used for assessments and one withdrew consent without
giving a reason. Three people also withdrew from the
combined group: hypertension was discovered in one
individual, one was unable to tolerate the cycle ergom-
eter and one withdrew consent without giving a reason.
All remaining participants were included in the analy-
sis. Participant descriptives and baseline measures can
be found in Table 1. ANOVA revealed no diﬀerence in
baseline measures between groups.
Results from the intervention are displayed in
Table 2. While we had some missing values that req-
uired multiple imputation, measure completion was
high, with 16% missing values in the primary measure.
When between-group measures were considered, no
diﬀerence was found between intervention groups for
any measure (p> 0.05). However there were trends in
the data.
For the primary outcome measure (the 2min walk
test) the data indicated a trend that 0 to 6week
improvements were greatest in the intermittent group.
The mean change for the intermittent group at 6weeks
was 12.94 4.71m (95% CI: 3.97 to 21.92) compared
with 4.71 4.24m (95% CI: 3.80 to 13.22) for the
continuous group and 0.9 1.9m (95% CI: 4.7 to
2.9) for the combined group. There was a trend for SF-
36 score to be maintained in the continuous group after
the 6 to 12week training period, contrary to the total
signiﬁcant reduction in SF-36 observed (p< 0.05), with
a mean increase in score of 1.6 2.6 (95% CI: 3.7 to
6.9) compared with a reduction in both combined and
intermittent scores of 7.6 2.9 (95% CI: 13.3 to
1.9) and 7.6 2.8 (95% CI: 13.2 to 2.06)
respectively. The continuous group also showed a
trend toward maintaining improvements following the
intervention. At the 24weeks assessment mean change
in 2min walk was 0.03 6.29m (95% CI: 12.65 to
12.59), TUG was 1.1 1.6 s (95% CI: 2.2 to 4.3) and
leg power 1.7 5.1W (95%: 8.5 to 11.9). There was a
trend for more improvement in leg power in the inter-
mittent and combined groups: 12weeks improvements
of 22.8 7.1W (95% CI: 8.6 to 37.0) and 17.5 7.3W
(95% CI: 2.8 to 32.1) respectively and 7.5 6.7W (95%
CI: 6.0 to 21.0) for the continuous group.
When all participants were considered (Total)
(Table 2), repeated measures ANOVA revealed signiﬁ-
cant improvements in mobility as indicated by 2min
walk distance (p< 0.01) and TUG time (p< 0.05)
at the 6week assessment. Leg power also improved at
the 6week assessment (p< 0.01) and continued to
improve at the 12week assessment (p< 0.01). No
other diﬀerence was found between the 6 and 12week
assessments, except for SF-36 score (p< 0.05), which
decreased, indicating a reduction in perceived general
health status. Twelve weeks after the end of interven-
tion (24week assessment), TUG performance
(p< 0.05), leg power (p< 0.01) and peak power on the
exercise test (p< 0.05) had decreased. There was no sig-
niﬁcant (p> 0.05) change in fatigue between assess-
ments as indicated by FSS score.
With regard to safety of and compliance with the
three programmes, Figure 1 shows the ﬂow of partici-
pants throughout; three participants from the com-
bined exercise group reported adverse events during
the exercise intervention phase (tachycardia, leg pain
and exacerbation of a knee injury) and a further ﬁve
participants withdrew from the study (due to personal
problems, work commitments and family commit-
ments, and two withdrew consent without giving a
reason). In the intermittent group four participants
discontinued the intervention due to adverse events
(two due to pain during cycling, one because of an
exacerbation of MS symptoms and one due to a loss
of consciousness during cycling) and one individual
withdrew from the study at this stage due to a planned
surgical procedure. There were no adverse events asso-
ciated with the continuous group, but one individ-
ual withdrew from the study during the intervention
phase.
Forty-one (75%) individuals who received the inter-
vention completed the entire 12week intervention
schedule (Combined: nine (53%); Continuous: 19
(95%); Intermittent: 13 (72%). Table 3 shows the
mean intervention sessions attended from 0 to 6weeks
and from 6 to 12weeks; there were signiﬁcantly
(p< 0.01) fewer sessions attended from 6 to12weeks.
Table 3 also shows the mode number of sessions
attended from 0 to 6weeks and from 6 to 12weeks,
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with the number of sessions most often attended
being greatest for the continuous group. Mean heart
rate data recorded every 2min during the ﬁrst exercise
sessions in week 1 and week 11 are also shown in
Table 3. There was no diﬀerence between groups in
number of sessions attended, but the continuous
group showed a trend toward attending more exercise
sessions. There was no signiﬁcant diﬀerence in heart
rates (p> 0.05) recorded during sessions or between
groups.
Discussion
When directly comparing diﬀerent exercise intensities
delivered using the same mode of exercise, cycling,
and the same relative amount of total work done in a
session, we found that 6weeks of exercise were associ-
ated with statistically beneﬁcial eﬀects on mobility and
leg power that were at least maintained during a further
6weeks of exercise for all training programmes with no
diﬀerences between groups. While we did not ﬁnd
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Figure 1. Flow diagram of the progress of participants through the study.
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signiﬁcant diﬀerences between the three diﬀerent exer-
cise intensity groups, post hoc analysis on the primary
outcome measure revealed that the higher-intensity
intermittent exercise group would have achieved signif-
icantly greater improvements in walking mobility if the
study had been powered with a sample size of 123. This
ﬁnding and the level of compliance support the imple-
mentation of a phase III trial.
Importantly, however, we also observed that contin-
uous low-intensity exercise seemed to be better toler-
ated when the number of adverse events, session
attendance and number of withdrawals during the
intervention period were considered, suggesting that
higher-intensity exercise may be less well tolerated by
people with MS. We thus suggest that a future trial
exploring exercise intensity should be approached
with caution, and that, though higher intensities may
oﬀer greater beneﬁts for some, continuous exercise per-
formed at an intensity that falls within an aerobic zone
is safe and will beneﬁt mobility and leg power, and
should currently be recommended by clinicians for
people with MS.
Table 2. Difference in outcome measured between assessments
Difference 0 to 6weeks Difference 6 to 12weeks Difference 12 to 24weeks
2min walk (m)
Total 7.0 2.6 (1.8 to 12.1)#, 0.25 1.7 1.5 (4.6 to 1.3), 0.01 7.1 3.8 (14.7 to 0.6), 0.07
Combined 3.2 4.6 (6.0 to 12.5), 0.04 0.5 2.6 (5.7 to 4.8), 0.02 9.7 6.8 (23.4 to 4.0), 0.08
Continuous 4.7 4.2 (3.8 to 13.2), 0.06 2.1 2.4 (6.9 to 2.7), 0.03 0.0 6.3 (12.7 to 12.6), 0.00
Intermittent 12.9 4.7 (4.0 to 21.9), 0.28 2.4 2.5 (7.4 to 2.7), 0.06 11.4 6.6 (24.7 to 1.9), 0.20
TUG (s)
Total 2.3 1.0 (4.4 to 0.2)*, 0.09 0.6 0.4 (1.4 to 0.1), 0.04 2.4 0.9 (0.5 to 4.2)*, 0.10
Combined 0.9 1.9 (4.7 to 2.9), 0.03 1.7 0.6 (3.1 to 0.3), 0.14 4.9 1.7 (1.5 to 8.3), 0.20
Continuous 3.5 1.7 (6.9 to 0.0), 0.10 0.3 0.6 (1.6 to 1), 0.02 1.1 1.6 (2.2 to 4.3), 0.03
Intermittent 2.5 1.8 (6.2 to 1.2), 0.22 0.0 0.7 (1.3 to 1.4), 0.00 1.1 1.6 (2.2 to 4.3), 0.16
Leg power (W)
Total 19.4 4.1 (11.2 to 27.6)#, 0.29 15.9 4.1 (7.8 to 24.1)#, 0.21 10.9 3.1 (17.1 to 4.8)#, 0.16
Combined 24.9 7.4 (10.1 to 39.7), 0.47 17.5 7.3 (2.8 to 32.1), 0.33 16.6 5.5 (27.7 to 5.6), 0.40
Continuous 20.2 6.8 (6.5 to 33.8), 0.38 7.5 6.7 (6.0 to 21.0), 0.09 1.7 5.1 (8.5 to 11.9), 0.01
Intermittent 13.1 7.2 (1.3 to 27.5), 0.12 22.8 7.1 (8.6 to 37.0), 0.27 18.0 5.3 (28.7 to 7.3), 0.35
Peak power on exercise test (W)
Total 3 2 (2 to 8), 0.03 2 2 (2 to 5), 0.02 29 5 (39 to 20)*, 0.42
Combined 2 4 (6 to 10), 0.01 3 3 (10 to 4), 0.06 33 8 (49 to 16), 0.41
Continuous 0 4 (8 to 8), 0.00 7 3 (1 to 13), 0.14 19 8 (35 to 4), 0.32
Intermittent 7 4 (1 to 15), 0.23 1 3 (6 to 8), 0.01 37 8 (53 to 20), 0.54
FSS
Total 0.0 0.1 (0.2 to 0.2), 0.00 0.0 0.1 (0.2 to 0.3), 0.00 0.0 0.1 (0.2 to 0.2), 0.00
Combined 0.2 0.2 (0.6 to 0.2), 0.06 0.0 0.2 (0.4 to 0.4), 0.00 0.2 0.2 (0.5 to 0.3), 0.20
Continuous 0.1 0.2 (0.3 to 0.4), 0.01 0.0 0.2 (0.4 to 0.4), 0.00 0.2 0.2 (0.2 to 0.6), 0.01
Intermittent 0.2 0.2 (0.2 to 0.6), 0.05 0.1 0.2 (0.3 to 0.5), 0.01 0.2 0.2 (0.5 to 0.2), 0.03
SF36
Total 1.7 1.4 (1.0 to 4.5), 0.02 4.5 1.6 (7.7 to 1.4)*, 0.11 1.7 2.4 (6.6 to 3.1), 0.01
Combined 5.6 2.5 (0.6 to 10.5), 0.18 7.6 2.9 (13.3 to 1.9), 0.27 1.8 4.3 (10.5 to 6.9), 0.01
Continuous 0.6 2.3 (5.2 to 4.0), 0.00 1.6 2.6 (3.7 to 6.9), 0.03 4.9 4.0 (13.0 to 3), 0.10
Intermittent 0.2 2.4 (4.6 to 5.0), 0.00 7.6 2.8 (13.2 to 2.06), 0.27 1.6 4.2 (6.9 to 10.1), 0.10
Barthel Index
Total 0.2 0.2 (0.1 to 0.5), 0.03 0.6 0.2 (1.1 to 0.1), 0.11 0.1 0.2 (0.4 to 0.5), 0.00
Combined 0.0 0.3 (0.5 to 0.5), 0.00 0.9 0.4 (1.7 to 0.0), 0.16 0.4 0.4 (0.4 to 1.3), 0.07
Continuous 0.8 0.3 (0.2 to 1.3), 0.27 0.4 0.4 (1.2 to 0.4), 0.09 0.0 0.3 (0.8 to 0.8), 0.00
Intermittent 0.2 0.3 (0.7 to 0.4), 0.03 0.5 0.4 (1.2 to 0.4), 0.08 0.2 0.4 (1.0 to 0.6), 0.02
Results expressed as mean  SE (95% confidence intervals), effect size (partial eta squared).
*p< 0.05, #p< 0.01 between assessments.
FFS: Fatigue Severity Scale, PASE: Modified Physical Activity Scale for the elderly, TUG: time up and go.
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Our ﬁnding that cycling exercise was associated with
improvement in walking in people with MS supports
the literature that cycling exercise beneﬁts mobility.16
However, eﬀect sizes suggest that improvements in
walking mobility were small. Mean improvement for
2min walk and TUG at 6weeks for all training pro-
grammes were comparable to 7% and 13% respec-
tively. A 12% increase in walking speed and a
23–24% improvement in TUG has been reported as
genuine change for an individual with MS.8 However,
the individual response to the interventions varied con-
siderably, as indicated by large conﬁdence intervals.
Rampello et al.17 found signiﬁcant improvement in
walking distance using the 6min walk test after
8weeks of 30min sessions of aerobic cycling three
times weekly at 60% of maximum power. The ﬁndings
from the present study suggest that mobility improve-
ments may be gained over 6weeks with an average of
only eight sessions of either 20min continuous, 15min
combined or 10min intermittent exercise performed in
a 20min session. During the second 6week period exer-
cise eﬀects were maintained despite individuals only
attending an average of six sessions. Although the pre-
sent study did not include health markers, the eﬀect of
exercise intervention on walking is an important con-
sideration when giving exercise guidance for this group.
Walking mobility has been reported as the highest con-
cern of people with MS, and it is an important factor in
determining independence in activities of daily living
and quality of life.18 Therefore these ﬁndings are impor-
tant to build a picture of a lower minimal exercise dose
for functional improvement in people with MS com-
pared with the government guidance for healthy
individuals.1
Dalgas et al.5 postulated that intense endurance
training might be expected to produce faster and
larger training improvements. We did observe a trend
towards a better outcome in the 2min walk in the inter-
mittent high-intensity exercise group. Post hoc analysis
shows that a total sample size of 123 would be needed
to conﬁrm its superiority (alpha 0.05, power 0.8). In
addition, while the present study failed to ﬁnd signiﬁ-
cant diﬀerences in leg power between groups, the con-
tinued improvement in leg power from 6 to 12weeks
may also be more associated with the higher-intensity
exercise groups. Certainly the training stimulus associ-
ated with high-intensity cycling would be expected to
produce greater leg power improvements.6 It may be
that higher-intensity exercise may improve certain func-
tional activities and oﬀer a better outcome for some
people with MS.
Walking speed has been related to muscle strength
in people with MS,19 and intervention utilizing resis-
tance training has been shown to improve lower limb
muscle performance and walking mobility mea-
sures.20,21 In the present study leg extensor power
was used to measure lower limb muscle performance.
Both mobility and leg power increased after 6weeks of
training. However, despite leg power continuing to
improve after 12weeks of training, mobility improve-
ments were stable. This may be due to cycling being
more analogous to the muscle action required for leg
extensor power measurement than that required for
walking. Certainly, task-speciﬁc training is associ-
ated with improved muscle synergy and
coordination.22
The present study found no changes in fatigue over
the study period, in agreement with the literature that
exercise at least does not have a negative eﬀect on fati-
gue.5 The FSS has also been used to indicate quality of
life (QOL) in people with MS,23 but, while our FSS
data suggest that fatigue was not aﬀected, the SF-36
Table 3. Exercise sessions
0 to 6weeks 6 to 12weeks
Sessions attended
Total 8 3 (10,11) 6 4* (10)
Combined 7 4 (1,10) 5 5 (0)
Continuous 9 3 (11) 7 3 (10)
Intermittent 8 3 (6) 5 4 (0,1,9)
% max heart rate
Total 66.8 11.6 64.1 8.7
Combined 67.4 14.1 60.6 6.9
Continuous 66.3 9.4 66.5 8.4
Intermittent 66.4 10.3 62.9 9.3
Sessions attended: results expressed as mean SD (mode).
% max heart rate: % age predicted maximum heart rate (220 age), values from training week 1 exercise session (0 to 6weeks) and week 11 exercise
session (6 to 12weeks).
*Significant difference in number of sessions between 0 to 6weeks and 6 to 12weeks (p< 0.01).
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data (another more widely used measure of QOL23,24)
suggest that QOL was signiﬁcantly reduced after
12weeks of training. This result is contrary to other
exercise studies; a meta-analysis on the eﬀect of exercise
training on QOL ﬁnding small but statistically signiﬁ-
cant improvements in QOL with exercise in people with
MS.23. While demonstrating good reliability and inter-
nal consistency when used in MS, the SF-36 is criticized
for lack of responsiveness in rehabilitation.10 Although
the negative eﬀect on the SF-36 score observed in the
present study after 12weeks of cycling should be trea-
ted with caution, it may have importance, since, despite
the study being underpowered to detect a between-
group eﬀect, the negative eﬀect was more associated
with higher-intensity exercise (intermittent and com-
bined). However, other studies with similar within-
group sample sizes investigating strengthening and
more intensive short periods of exercise have found
improvements in the SF-36 after exercise.24,25
The adverse events that occurred during the inter-
vention period of the current study were also associated
with the higher-intensity exercise groups. In the inter-
mittent group there were four adverse events during the
intervention period, and three in the combined group.
Two of the adverse events in the intermittent group
required inpatient hospitalization, one due to loss of
consciousness and one due to exacerbation of MS
symptoms. It became apparent that loss of conscious-
ness events were an existing problem of the participant.
In agreement with other exercise studies that have
reported exacerbation of MS symptoms,3 it was
deemed by the study steering group that the exacerba-
tion of MS symptoms was unlikely to have been caused
by the intervention. The reports of leg pain may be of
more importance when considering delivering higher-
intensity cycling exercise, as two individuals withdrew
from the intervention due to leg pain during cycling in
the intermittent group and one in the combined group,
with a further individual aggravating an existing knee
injury. These events suggest that higher-intensity
cycling exercise may not be appropriate for some
people with MS, and that leg pain should be monitored
while delivering the exercise. There was no diﬀerence in
the number of sessions attended between groups, but a
trend toward attending more sessions in the continuous
group.
A pragmatic approach was used to determine the
sample size of the present study. While the results
show that this was insuﬃcient to ﬁnd diﬀerences
between groups, this limitation is common among MS
exercise studies,4 and not surprising with the heteroge-
neous group recruited. Applying CONSORT26 guide-
lines to reporting of this trial allows critical appraisal
and interpretation of the results and provides evidence
for meta-analysis.
Apart from the small sample size, our study has sev-
eral other limitations. We included only people who
were capable of cycling and performing the 2min
walk test. However, we did have a heterogeneous
group of individuals, including some people in the
very early stages of the disease. While we asked partic-
ipants to do a ﬁxed dose, we found that many could not
maintain the twice weekly intervention schedule, and,
although our within-session exercise was carefully con-
trolled, the total dose was much less than we intended.
Nonetheless, we unexpectedly found beneﬁts occurring
with low doses of exercise. Importantly, we found that
an average of eight sessions of 20mins of cycling exer-
cise had an eﬀect in the ﬁrst 6weeks and that an aver-
age of six sessions maintained this eﬀect over the
following 6week period, suggesting that lower doses
of exercise may beneﬁt people with MS. When partici-
pants were measured 12weeks after training ﬁnished,
detraining had occurred in mobility measures,
with again no diﬀerence between groups. Achieving
ongoing physical activity would appear to be important
for people with MS. Future studies should include
health markers in order to further establish health
beneﬁts.
Interpreting diﬀerences between types of exercise
therapy for people with MS from previous research
has been found to be diﬃcult due to poorly described
interventions and research into diﬀerent abilities.4 This
research study has utilized a design that controlled and
described the intervention and was delivered using the
same mode. Thus we can attribute diﬀerences between
groups to intensity. While we have considered the lim-
itations of the study, the trial has certain strengths,
including its design, full recruitment, inclusion of a
wide range of abilities, good utility and completion of
outcome measures and compliance with the interven-
tion. We thus propose that our observations are impor-
tant and valid and should be considered in the planning
of future trials and in forming the evidence to develop
exercise guidance for people with MS.
Conclusions
Cycling exercise delivered over a 6week period pro-
duces signiﬁcant beneﬁts for mobility and leg power,
which are maintained and improved with further
weekly sessions. While higher-intensity exercise may
oﬀer greater beneﬁts for some, 20min of continuous
cycling exercise with heart rate maintained in an aero-
bic zone is better tolerated. This approach may be
implemented safely in community exercise centres.
Further studies may wish to explore optimal exercise
frequency for this exercise approach or explore eﬀect
over the longer term.
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